Semaglutide 2mg

Aprašymas

Semaglutide is a peptide-structured experimental compound described in scientific literature as a model of GLP-1 (glucagon-like peptide-1) receptor agonism.

It is characterized by the following:

• interacts with the GLP-1 receptor system;
• mimics the mechanisms of endogenous GLP-1 activity;
• is analyzed as a single-receptor activation model in experimental studies.

This compound is examined in a scientific research context, assessing the regulation of metabolic processes and hormonal signal transmission.

Scientific context

In the literature, Semaglutide is associated with studies analyzing:

• mechanisms of glucose metabolism regulation;
• models of energy balance and appetite control;
• hormonal signaling in the digestive system;
• the effects of GLP-1 receptor activation on body systems.

All of this information is provided strictly for scientific and educational purposes.

Key characteristics

• Single-action model (GLP-1 receptor system);
• Peptide-based compound;
• Lyophilized form;
• High-purity laboratory standard;
• Intended for scientific and laboratory research use only.

Composition

• Active substance: Semaglutide – 2 mg
• Form: Lyophilized powder

Storage conditions

• Store at 2–8 °C
• Do not freeze
• Protect from direct light
• Keep tightly sealed
• Keep out of reach of children

Important information

• The product is not a medicinal product;
• The product is not a dietary supplement;
• Not intended for use in humans or animals;
• Not intended for diagnosis, treatment, or prevention of diseases;
• Intended for laboratory, scientific, and educational purposes only.